SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-004348
Filing Date
2017-05-10
Accepted
2017-05-10 16:31:29
Documents
48
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tenx_10q.htm 10-Q 582680
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF tenx_ex311.htm EX-31.1 12254
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE tenx_ex321.htm EX-32.1 7476
  Complete submission text file 0001654954-17-004348.txt   2503169

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tenx-20170331.xml EX-101.INS 497650
5 XBRL TAXONOMY EXTENSION SCHEMA tenx-20170331.xsd EX-101.SCH 25940
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20170331_cal.xml EX-101.CAL 31984
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20170331_def.xml EX-101.DEF 45024
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20170331_lab.xml EX-101.LAB 176261
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20170331_pre.xml EX-101.PRE 130715
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34600 | Film No.: 17830776
SIC: 8731 Services-Commercial Physical & Biological Research